BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 28302487)

  • 1. TUG1 mediates methotrexate resistance in colorectal cancer via miR-186/CPEB2 axis.
    Li C; Gao Y; Li Y; Ding D
    Biochem Biophys Res Commun; 2017 Sep; 491(2):552-557. PubMed ID: 28302487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. H19 mediates methotrexate resistance in colorectal cancer through activating Wnt/β-catenin pathway.
    Wu KF; Liang WC; Feng L; Pang JX; Waye MM; Zhang JF; Fu WM
    Exp Cell Res; 2017 Jan; 350(2):312-317. PubMed ID: 27919747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA KCNQ1OT1 enhanced the methotrexate resistance of colorectal cancer cells by regulating miR-760/PPP1R1B via the cAMP signalling pathway.
    Xian D; Zhao Y
    J Cell Mol Med; 2019 Jun; 23(6):3808-3823. PubMed ID: 30997746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor 2 mRNA-binding protein 2-stabilized long non-coding RNA Taurine up-regulated gene 1 (TUG1) promotes cisplatin-resistance of colorectal cancer via modulating autophagy.
    Xia C; Li Q; Cheng X; Wu T; Gao P; Gu Y
    Bioengineered; 2022 Feb; 13(2):2450-2469. PubMed ID: 35014946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA TUG1 mediates 5-fluorouracil resistance by acting as a ceRNA of miR-197-3p in colorectal cancer.
    Wang M; Hu H; Wang Y; Huang Q; Huang R; Chen Y; Ma T; Qiao T; Zhang Q; Wu H; Chen Q; Han D; Wang G; Wang X
    J Cancer; 2019; 10(19):4603-4613. PubMed ID: 31528224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of MEG3 sensitizes colorectal cancer cells to oxaliplatin through regulation of miR-141/PDCD4 axis.
    Wang H; Li H; Zhang L; Yang D
    Biomed Pharmacother; 2018 Oct; 106():1607-1615. PubMed ID: 30119236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LncRNA CCAT1 modulates the sensitivity of paclitaxel in nasopharynx cancers cells via miR-181a/CPEB2 axis.
    Wang Q; Zhang W; Hao S
    Cell Cycle; 2017 Apr; 16(8):795-801. PubMed ID: 28358263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA TUG1 promotes the progression of colorectal cancer via the miR-138-5p/ZEB2 axis.
    Yan Z; Bi M; Zhang Q; Song Y; Hong S
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32391554
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel long noncoding RNA, LINC00483 promotes proliferation and metastasis via modulating of FMNL2 in CRC.
    Yan Y; Wang Z; Qin B
    Biochem Biophys Res Commun; 2019 Feb; 509(2):441-447. PubMed ID: 30594388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional role of a long non-coding RNA LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy.
    Liu K; Yao H; Wen Y; Zhao H; Zhou N; Lei S; Xiong L
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2871-2880. PubMed ID: 29807108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
    Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
    J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knockdown of Long Non-Coding RNA XIST Inhibited Doxorubicin Resistance in Colorectal Cancer by Upregulation of miR-124 and Downregulation of SGK1.
    Zhu J; Zhang R; Yang D; Li J; Yan X; Jin K; Li W; Liu X; Zhao J; Shang W; Yu T
    Cell Physiol Biochem; 2018; 51(1):113-128. PubMed ID: 30439718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The lncRNA TUG1 promotes cell growth and migration in colorectal cancer via the TUG1-miR-145-5p-TRPC6 pathway.
    Wang X; Bai X; Yan Z; Guo X; Zhang Y
    Biochem Cell Biol; 2021 Apr; 99(2):249-260. PubMed ID: 32985219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. lncRNA MCM3AP-AS1 inhibits the progression of colorectal cancer via the miR-19a-3p/FOXF2 axis.
    Dai W; Zeng W; Lee D
    J Gene Med; 2021 Mar; 23(3):e3306. PubMed ID: 33450091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA TUG1 interacting with miR-144 contributes to proliferation, migration and tumorigenesis through activating the JAK2/STAT3 pathway in hepatocellular carcinoma.
    Lv J; Kong Y; Gao Z; Liu Y; Zhu P; Yu Z
    Int J Biochem Cell Biol; 2018 Aug; 101():19-28. PubMed ID: 29791864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA LUCAT1 modulates methotrexate resistance in osteosarcoma via miR-200c/ABCB1 axis.
    Han Z; Shi L
    Biochem Biophys Res Commun; 2018 Jan; 495(1):947-953. PubMed ID: 29170124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-505 mediates methotrexate resistance in colorectal cancer by targeting RASSF8.
    Chen Y; Bian L; Zhang Y
    J Pharm Pharmacol; 2018 Jul; 70(7):937-951. PubMed ID: 29726011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
    Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
    Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncogenic lncRNA ZNF561-AS1 is essential for colorectal cancer proliferation and survival through regulation of miR-26a-3p/miR-128-5p-SRSF6 axis.
    Si Z; Yu L; Jing H; Wu L; Wang X
    J Exp Clin Cancer Res; 2021 Feb; 40(1):78. PubMed ID: 33622363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated lncRNA Cyclin-dependent kinase inhibitor 2B antisense RNA 1 induces the proliferation and migration of colorectal cancer by miR-378b/CAPRIN2 axis.
    Zheng Y; Zeng J; Xia H; Wang X; Chen H; Huang L; Zeng C
    Bioengineered; 2021 Dec; 12(1):5476-5490. PubMed ID: 34511033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.